Hydrochlorothiazide (HCTZ)
Hydrochlorothiazide (HCTZ) is a pharmaceutical drug with 18 clinical trials. Historical success rate of 88.9%.
Success Metrics
Based on 16 completed trials
Phase Distribution
Phase Distribution
6
Early Stage
2
Mid Stage
9
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
88.9%
16 of 18 finished
11.1%
2 ended early
0
trials recruiting
18
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Use of Nanotechnology Structured Water for the Prevention of Recurrent Stone Formation
Diuretic Comparison Project
Salt Loading and Thiazide Intervention Study
Bioequivalence of Losartan and Hydrochlorothiazide (HCTZ) Combination Tablet and Coadministration of Its Components (0954A-306)
Aldosterone and the Metabolic Syndrome
Clinical Trials (18)
Use of Nanotechnology Structured Water for the Prevention of Recurrent Stone Formation
Diuretic Comparison Project
Salt Loading and Thiazide Intervention Study
Bioequivalence of Losartan and Hydrochlorothiazide (HCTZ) Combination Tablet and Coadministration of Its Components (0954A-306)
Aldosterone and the Metabolic Syndrome
A Study of MK-7145 Compared to Placebo and Hydrochlorothiazide for Lowering Blood Pressure in Male Participants With Hypertension (MK-7145-009)
Aliskiren HCTZ Compared to Amlodipine in Patients With Stage 2 Systolic Hypertension and Diabetes Mellitus
A Long-term (12 Months) Safety, Tolerability and Efficacy Study of LCZ696 in Patients With Essential Hypertension
A Study to Investigate the Magnitude and Duration of Response of MK0954 Compared to Placebo in Patients With Hypertension (0954-021)(COMPLETED)
Multiple Dose Effects of Hydrochlorothiazide and Isosorbide Mononitrate on Glucose Homeostasis (MK-0000-117)(Completed)
Influence of Food on the Bioavailability of Two Doses of Telmisartan/HCTZ Fixed-dose Combination in Japanese Healthy Male Volunteers
ALiskiren or Losartan Effects on bioMARKers of Myocardial Remodeling
A Randomized Controlled Trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly People
A Safety and Tolerability Study of the Combination of Aliskiren/Valsartan in Patients With High Blood Pressure, Followed by Long-term Safety and Tolerability of Aliskiren, Valsartan and Hydrochlorothiazide.
To Study the Effects of Aliskiren on Albuminuria and Various Biomarkers in Patients With Nephropathy
A Study To Compare Effects Of GSK189075 In Combination With Either Furosemide Or Hydrochlorothiazide
Safety and Efficacy of Valsartan vs Atenolol and Hydrochlorothiazide Combination on Blood Flow in Hypertensive Patients
Efficacy and Safety of Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Moderate-severe Hypertension
All 18 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 18